We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
LHHEALTH-D NAV, returns, dividends and fees — LH HEALTH INNOVATION FUND | Robowealth
Shows where this fund stands in its group. Not investment advice · Data as of 13 Nov 2026
NAV per unit
NAV (THB/unit) · 13 Nov 20266.3573YTD+0.8084 (+14.57%)
Risk
7
MDD
−9.3%
Dividend
Pays
AUM
32.58M
0.00%
NAV change over the selected periodN/A
Invests across funds within the same AMCSector fundCurrency hedged 80.26%
What it invests in
Fact sheet data as of 30 Oct 2026
LHHEALTH-D invests through the master fund AB International Health Care Portfolio 96.78%
This fund
LHHEALTH-D
Invests in units of another fund
→
The fund that actually invests
AB International Health Care Portfolio
I USD · Luxembourg
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
The fund spreads its money across many companies
Top 10 companies combined 54.08% of fund value
Other stocks and cash
The fund's allocation: Johnson & Johnson 9.43%, Eli Lilly and Co 9.14%, Merck & 6.22%, Unitedhealth Group 6.16%, Roche 5.15%, Novartis 4.20%, AstraZeneca 3.72%, Vertex Pharmaceuticals 3.66%, Gilead Sciences 3.61%, Bristol-Myers Squibb Co 2.80%, and other stocks and cash 45.92%
Past performance is not a guarantee of future results
Go deeper
Yearly returns
Up in 2 of 4 years · best 2025 +5.14% · worst 2022 −34.41%
Monthly returns
Positive months: 36 of 63 (57%) · Best Oct 2026 +9.34% · Worst Jan 2022 −22.99%
Tap a year to see its months · * part year
Year
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
+0.0
+2.1
−6.5
−0.5
+1.4
+5.0
+1.0
+3.5
−2.1
+9.3
+1.2
·
2025
+4.6
+1.0
−2.4
−2.5
−4.6
+0.7
−4.3
+3.2
+1.6
+3.1
+6.6
−1.4
2024
+2.6
+2.9
+2.1
−5.4
+3.1
+2.3
+0.3
+3.9
−4.8
−4.8
−0.1
−7.3
2023
+1.0
−5.9
+2.6
+2.7
−3.6
+2.2
+0.9
+0.3
−2.5
−3.0
+4.3
+3.8
2022
−23.0
−0.5
+4.8
−13.3
−3.9
−2.4
+5.0
+0.8
−7.3
+2.7
+1.7
−2.2
2021
·
·
·
·
·
·
·
·
−0.0
+0.9
−6.7
−6.7
Average
−3.0
−0.1
+0.1
−3.8
−1.5
+1.6
+0.6
+2.3
−2.5
+1.4
+1.2
−2.7
Holding returns: worst · median · best
Every start date since 28 Sep 2021 · 3 and 6 months are total % · 1 year and over is % per year
Worst to best (green = gain, red = loss)Half of all outcomes fall in this rangeMedian
Risk
Drawdown from peak
Largest drawdown in the selected period −51.61%Previous peak 4 Nov 2021 (NAV 9.8725) → Trough 7 Aug 2025 (NAV 4.7776) · Not back to the previous peak as of 13 Nov 2026
Currently −35.61% from the peak NAV of 9.8725 (4 Nov 2021)
Change between the 2 points
Below the previous peakLargest drawdown period (previous peak → recovery)Drawdown = NAV ÷ highest prior NAV in the selected period − 1Drag across the chart to pick 2 points (on a phone, hold with 2 fingers)
✓3 payments so far since Apr 22 totalling 0.3000 THB/unit
✓Pays consistently The longest gap between payments was 4 months
!Not guaranteed Dividends are paid from the fund's profit and may be reduced or suspended
Total dividends per year, by year of payment
0.202022
0.102023
THB/unit, totalled by year of payment · * 2026 to 13 Nov 2026
When a dividend is paid, NAV falls by the dividend amount on the book-close date (the D markers on the NAV chart). The value investors receive doesn't disappear; it moves from the unit price into cash
Individual investors have 10% withholding tax deducted from dividends · Returns and statistics on this page assume dividends are reinvested before tax
กองทุนมีนโยบายเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศ (หรือ “กองทุนหลัก (Master fund)”) เฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิ Its largest holdings are Johnson & Johnson 9.74% · Eli Lilly & Co 9.44% · Merck & Co., Inc 6.43% (fact sheet 30 Oct 2026)
How risky is it?+−
Risk level 7 of 8 (High risk). Since 28 Sep 2021, its NAV has fallen as much as −51.61% from its peak.
What are the fees?+−
Actual total expense ratio (TER) 2.16% a year, against a ceiling of 5.00%. Management fee 1.61%. Front-end fee 1.25%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
Does it pay dividends?+−
Yes. The latest was 0.1000 THB per unit, book close 30 Dec 2022, paid 9 Jan 2023 · 3 payments so far, totalling 0.3000 THB per unit. Dividends are subject to 10% withholding tax and are not guaranteed
What is the minimum purchase, and when do I get my money after selling?+−
Minimum first purchase 1,000 THB, subsequent purchases 100 THB. Buy orders accepted until 14:00, sell orders until 14:00, and redemption proceeds are paid T+4
Does it hedge currency risk?+−
Hedged at the manager's discretion. As of 30 Sep 2026, 80.26% of the value of its foreign investments was hedged
How is LHHEALTH-D different from LHHEALTH-A / LHHEALTH-ASSF / LHHEALTH-DSSF / LHHEALTH-E?+−
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · LHHEALTH-D: pays dividends, TER 2.16% · LHHEALTH-A: no dividends, TER 2.16% · LHHEALTH-ASSF: no dividends, TER 2.16% · LHHEALTH-DSSF: pays dividends, TER 2.16% · LHHEALTH-E: no dividends, TER 2.16%
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Based on the master fund's share of this fund's value (96.78% as of 30 Sep 2026) × each stock's weight in the master fund · fact sheet from AllianceBernstein · Illustrations are for explanation only, not individual stock recommendations
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Only No tax benefit share classes are counted, and only funds with a full track record for the period are included · Calculated from NAV as of 13 Nov 2026